1. Home
  2. RYI vs EYPT Comparison

RYI vs EYPT Comparison

Compare RYI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$25.30

Market Cap

650.0M

Sector

Industrials

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$17.80

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
EYPT
Founded
1842
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
650.0M
1.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
RYI
EYPT
Price
$25.30
$17.80
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$25.00
$29.60
AVG Volume (30 Days)
378.9K
1.3M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
2.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,473,900,000.00
$42,339,000.00
Revenue This Year
$0.38
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.18
$3.91
52 Week High
$27.41
$19.11

Technical Indicators

Market Signals
Indicator
RYI
EYPT
Relative Strength Index (RSI) 64.40 66.36
Support Level $23.57 $16.52
Resistance Level $26.39 $17.40
Average True Range (ATR) 0.99 1.08
MACD 0.19 0.02
Stochastic Oscillator 78.42 71.27

Price Performance

Historical Comparison
RYI
EYPT

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: